Understanding Modern Diagnoses with Unknown Gene Plays a Critical Role in Inherited Thrombophilia
Overview
Protein C deficiency (PCD) is found in 1 out of 200 to 500 persons in the general global population. Inherited thrombophilia is characterized by an increased tendency of blood to clot in human blood vessels. It is caused by several factors including mutations in the genes involved in thrombin binding, protein c activation and numerous clotting factors. The purpose of this study is to identify the underlying genes that lead to PCD in patients with nationality in Saudi Arabia, so that a diagnosis can be potentially discovered. To begin the research, families with PCD were recruited. Targeting all coding exons of the human genome was performed using Illumina NextEra library preparation kits. This was followed by the paired-end sequencing on Illumina NextSeq500 instrument. Reads quality control was performed and the reads were aligned to the reference genome using Burrows-Wheeler Aligner (BWA). Variants calling and annotation were performed using Genome Analysis Tool Kit (GATK). All known genes involved in causing PCD were excluded by whole exome sequencing. The genes that were previously reported to be involved in inherited thrombophilia were checked for any causative variant. No mutation has been identified in known genes. Currently, data analysis is focusing on identifying a novel gene underlying PCD. The goal of this study will hopefully pave the way to better understanding the disease pathophysiology and help in developing DNA based diagnosis, carrier screening and somatic gene therapy.
Competition history
- ISEF 2016
Resources
Related projects
ISEF · 2014
The CYP2C19 Polymorphisms in Saudi Population: Clinical Response to Clopidogrel in Coronary Artery Disease
CSEF · 2004
GENEalogy: Tracing a Mutant Gene through My Family Line
ISEF · 2020
Direct Oral Anticoagulants for Treatment of Thrombophilia
ISEF · 2015
Using Comparative Genomic Hybridization to Identify Unique Mutation in Duchenne Muscular Dystrophy Patients in Saudi Arabia
ISEF · 2024
A Novel Genomic Variant Algorithm for Identifying the Pathological Mechanism of Rare Genetic Diseases in Order to Target Personalized Therapies
ISEF · 2019
Evaluation of a Rare PMS1 Germline Variant as a Putative Hereditary Breast Cancer Risk Allele
CSEF · 2016
Developing a Low Cost Noninvasive Prenatal Diagnosis for Genetic Disorders
CSEF · 2015
HDX Mass Spectrometry Study to Identify a Key, New Thrombin-TM Complex Mechanism Used to Prevent Blood Clotting
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair